Drugs / Soolantra™
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | SOOLANTRA | — | 2014-12-19 | fda.gov ↗ |
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT07795567 Comparator | Dec 2025 → Jun 2026 | rosacea | Sun Pharmaceutical Industries, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Soolantra | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07795567 ↗ |
| Route | Topical | “self-applied topically” NCT07795567 ↗ |